Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Alzheimer's disease
Alzheimer's disease
FDA advisers reassert case against approval of Biogen's Alzheimer's drug
BioPharma Dive
Wed, 03/31/21 - 10:55 pm
Biogen
FDA
Alzheimer's disease
aducanumab
Biogen's Aducanumab: A Look at the Drug’s History and Recent Updates
BioSpace
Sat, 03/27/21 - 12:14 pm
Biogen
Eisai
aducanumab
Alzheimer's disease
Partner Therapeutics’ Leukine Shows Promise for Alzheimer’s in New Study
BioSpace
Wed, 03/24/21 - 11:18 pm
Partner Therapeutics
Leukine
clinical trials
Alzheimer's disease
Will Another Alzheimer's Disease Drug Bite the Dust After Lilly's Latest Results?
Motley Fool
Wed, 03/24/21 - 10:14 am
Eli Lilly
Alzheimer's disease
donanemab
Big pharma’s key catalysts in the second quarter
EP Vantage
Wed, 03/24/21 - 10:04 am
Biogen
Alzheimer's disease
aducanumab
Sanofi
breast cancer
FDA
Biogen outlines 10M-patient opportunity for Alzheimer's drug in US
Biopharma Reporter
Tue, 03/16/21 - 10:48 pm
Biogen
Alzheimer's disease
aducanumab
Lilly lays out 2-year plan to gain approval for Alzheimer's drug
BioPharma Dive
Tue, 03/16/21 - 12:04 am
Eli Lilly
donanemab
clinical trials
Alzheimer's disease
Why Eli Lilly's Successful Alzheimer's Disease Study Was So Disappointing
Motley Fool
Mon, 03/15/21 - 11:03 am
Eli Lilly
Alzheimer's disease
clinical trials
donanemab
Clinical Trial Begins For Gene Therapy To Treat Alzheimer’s Disease
Forbes
Fri, 03/12/21 - 10:33 am
gene therapy
UCSD
Alzheimer's disease
clinical trials
Lilly lines up its next shot at Alzheimer’s
EP Vantage
Thu, 03/11/21 - 10:39 am
Eli Lilly
donanemab
Alzheimer's disease
New Drug Approval Could Be on Horizon for Alzheimer’s after 17-Year Drought
BioSpace
Tue, 03/9/21 - 09:53 pm
Alzheon
Alzheimer's disease
ALZ-801
AI uncovers Eli Lilly's rheumatoid arthritis drug Olumiant as potential Alzheimer's treatment
Fierce Biotech
Mon, 03/8/21 - 10:42 am
Eli Lilly
olumiant
JAK inhibitors
artificial intelligence
Alzheimer's disease
Where Will Biogen Be in 5 Years?
Motley Fool
Tue, 02/23/21 - 10:40 am
Biogen
aducanumab
Alzheimer's disease
A safer Alzheimer's drug than Biogen's aducanumab? Denali-WashU drug shows better profile in mice
Fierce Biotech
Thu, 02/18/21 - 11:04 am
Alzheimer's disease
Denali Therapeutics
Biogen
aducanumab
HAE-4
Pfizer, Verily-backed Alzheimer's biotech Cortexyme hit by FDA partial hold over liver toxicity
Fierce Biotech
Tue, 02/16/21 - 11:10 am
Cortexyme
FDA
Pfizer
Verily
Alzheimer's disease
COR388
AC Immune has 'remarkable' Alzheimer's vaccine data. Just don't ask to see them
Endpoints
Thu, 02/11/21 - 10:53 am
AC Immune
Alzheimer's disease
vaccines
clinical trials
Roche refreshingly cautious on Alzheimer's hopeful gantenerumab amid growing hype from rivals
Fierce Biotech
Fri, 02/5/21 - 10:52 am
Roche
gantenerumab
Alzheimer's disease
Biogen laser-focused on Alzheimer's drug as rest of business falters
BioPharma Dive
Wed, 02/3/21 - 10:55 pm
Biogen
earnings
aducanumab
Alzheimer's disease
FDA extends review period for Biogen's Alzheimer's drug
Reuters
Fri, 01/29/21 - 10:06 am
Biogen
Eisai
FDA
aducanumab
Alzheimer's disease
Biohaven Provides Update On Phase 2/3 Trial And Alzheimer's Disease Program
BioSpace
Mon, 01/18/21 - 01:13 pm
Biohaven
Alzheimer's disease
clinical trials
troriluzole
Pages
« first
‹ previous
…
17
18
19
20
21
22
23
24
25
…
next ›
last »